EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS060-19423 
Organism
Homo sapiens 
Tissue/cell
GM12891 
Coordinate
chr2:68988350-68990240 
TF binding sites/motifs
Number: 5             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Arid5aMA0602.1chr2:68988764-68988778GCTATCAATATTAG-6.68
IRF1MA0050.2chr2:68989829-68989850AAAAGAAAAAAGAAACAAAAA-6.22
MEF2CMA0497.1chr2:68988968-68988983AAATTAAAAATAGAA+6.12
POU2F2MA0507.1chr2:68988735-68988748ATATGCAAATGGA-6.23
TCF7L2MA0523.1chr2:68988477-68988491CAACATCAAAGGCA+6.63
Number of super-enhancer constituents: 30             
IDCoordinateTissue/cell
SE_09157chr2:68988519-69004806CD14
SE_10171chr2:68988144-69004666CD19_Primary
SE_10879chr2:68985144-69041710CD20
SE_11846chr2:68989506-69004240CD3
SE_13358chr2:68988841-68999170CD34_Primary_RO01536
SE_14164chr2:68989274-68990969CD34_Primary_RO01549
SE_14434chr2:68988328-68990888CD4_Memory_Primary_7pool
SE_15442chr2:68989713-68999042CD4_Memory_Primary_8pool
SE_16342chr2:68989110-68999875CD4_Naive_Primary_8pool
SE_16991chr2:68989226-68993743CD4p_CD225int_CD127p_Tmem
SE_17374chr2:68987917-69005038CD4p_CD25-_CD45RAp_Naive
SE_17790chr2:68986557-69005062CD4p_CD25-_CD45ROp_Memory
SE_18271chr2:68987887-69005048CD4p_CD25-_Il17-_PMAstim_Th
SE_19336chr2:68989230-68999527CD4p_CD25-_Il17p_PMAstim_Th17
SE_20020chr2:68988773-69004950CD56
SE_21385chr2:68989224-69004511CD8_Memory_7pool
SE_22135chr2:68988582-69004200CD8_Naive_8pool
SE_22313chr2:68986626-69015805CD8_primiary
SE_25454chr2:68988067-68996396DND41
SE_31134chr2:68988963-68990654Fetal_Thymus
SE_39426chr2:68989457-68990421Jurkat
SE_50760chr2:68989500-68990321Sigmoid_Colon
SE_53380chr2:68989371-68990322Spleen
SE_58353chr2:68936255-69037867Ly1
SE_58815chr2:68915194-69067159Ly3
SE_60486chr2:68936463-69018341DHL6
SE_60993chr2:68936154-69024001HBL1
SE_61638chr2:68960465-69040086Toledo
SE_62221chr2:68936470-69037652Tonsil
SE_66438chr2:68989457-68990421Jurkat
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr26898966268990122
Enhancer Sequence
CCATATACAA AAATTAACTC AAAATGGACC TATGAACTAA ATTTAAGACC CCAAACTGTA 60
AAACTCTTAG AAGAAGACGT GGGGCAAAAA CTTCACAACA CTGAATTTGG CAATGATTTC 120
TTGGCTTCAA CATCAAAGGC ACAGGTAACA GAAGAAAAAA TAGTCAAATT AGACTTCTGA 180
AAATTTAAAA AATTACGTAT CAAAAGATAC TACCAACAGA GTAAAAAATC AACAGAATAG 240
GGGAAAATAT TTGCAAATCA TATATCTAAC AAGGGATTAA TATCCAGAAT GTATAAAAAG 300
CTCCTAAACT CTACAAAAAA AAACCCCACA AACAACTCAG TTCAAAAATG GGCAAAGGAC 360
TCAAATAGAC ATTTCTCCAA AGAAGATATG CAAATGGACA ATAAATGAAA TGATGCTATC 420
AATATTAGTA ATCATTAGGG AAATGCAACA CGAACTACAG CGAGATAGCA ACTCACACCC 480
ATTATGATGG CTGCTATTAA AAAACTGGAA GATAACAAAT GTTGGTGAGG ATGTGGAGAT 540
ATTGAAACCC TTTTGCACTG TTGGTGGAAA TGTTAAATGT TACAGCTACT ATGGAAAACA 600
GTATAGCAGT TCCACAAAAA ATTAAAAATA GAATTACTAT CTGATCCCAC AATTCCGCAT 660
CTAAATATAT ACTCAAAGAA TTGAAAACAG AGTCTTGAAG AGATATTTGT ACATCACGTT 720
CATAGCAGCA TCATTTGTAA TAACTAAAAC ATGGAGGCAA CCCAGGTGTC CATTGACAAA 780
TGAACTGACA AACAAAATGT GGTATATACA TTCAATAGAA TGTATTCAGC CTTAAAAAGG 840
AAGGACATTC TGCAATATGC TATAGCACCG ATGAATCTTG AGGACATTAT GCTAAGTGAA 900
ATAAGCTGCT TCAAAAAAGA CAAATGCTGT ATAATTCCAC TTATGTGAGG TGCTTAGAGG 960
AGACAAATTC ATAGAGACAG AAAGTAGAAT GGTGGTTACC AGGGCTAGGG AAAGAAGGAA 1020
AAGGAAGTTA ACTCTGTAAT GGGTACAGAA TTTCAGTTTT TCAAGATGAA AAGAGTTCTG 1080
AAAATGGATG GTGATGGTTG TGCAATAATG TGAATGTACT TAATACTACT GAACTGTACA 1140
ATCAAAAATA AGATAGTAAA TTTTATGTGT GTTTTACTGG AATAAAAATA ATTGGGAAAA 1200
AATAAATCAC GCAAGTTATA ATTTGAGAAA AATAGCCCAA GTCAAATATT ACAACTCATT 1260
TTTCATCTTC AAAAGCTCTC GTATGCTATT AGATGTGCTA AGCCAGAGGG ATTTGGAATT 1320
AGGACCGCAT CCTGGGGTCC CGGTGTTAGC CTGTTGAGTC ACCCCCTCAT GGTTCTCCTT 1380
CTTTTACCTC CTGTTTGTGC ATCTCTGGTT CCTGCTTCTT CAGCCTTTGC ACAAAAGCTT 1440
AGTTGGTCCT TCAGTGACTA CTGGCTAAAA ACAAACAGAA AAAGAAAAAA GAAACAAAAA 1500
TGGTGTTCTT CTAGTTCTTC CATGAGAACT GTGAAGGAGT GGCCAGCCAA AAAGAAATGT 1560
CAAGCAGAGG CTAGTGTGTG GGCCAAGAAA GTCCAGGTCA GACAGAAACA CTACAGTTGC 1620
TCACAGATAC ATACAAAATA AGTCCTGACA TTTTTGTGAG GACCTTGGGT GATAAAAGGG 1680
AAACCCCCTA ACACATTTTT CAGGCAGCTG ATAATGTTTG ACAGCTTTGA AGAGGAAACA 1740
GAACTACCAG ATGTCAGTGG CTGAATCACA GGGAAAATAC TGCATTCTGC AAAGCCTTAC 1800
TCAAGCATCA TGAAGTGTAG CCCAAAGTTG ATAGAAATGC TGATAAATAA TAAAATTTTA 1860
TGAAAAAGTA AAATCTCGAT ACTTTTTCAC 1890